1. Home
  2. ALDX vs MVIS Comparison

ALDX vs MVIS Comparison

Compare ALDX & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • MVIS
  • Stock Information
  • Founded
  • ALDX 2004
  • MVIS 1993
  • Country
  • ALDX United States
  • MVIS United States
  • Employees
  • ALDX N/A
  • MVIS N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • MVIS Industrial Machinery/Components
  • Sector
  • ALDX Health Care
  • MVIS Technology
  • Exchange
  • ALDX Nasdaq
  • MVIS Nasdaq
  • Market Cap
  • ALDX 133.7M
  • MVIS 287.6M
  • IPO Year
  • ALDX 2014
  • MVIS 1996
  • Fundamental
  • Price
  • ALDX $2.16
  • MVIS $1.15
  • Analyst Decision
  • ALDX Strong Buy
  • MVIS Buy
  • Analyst Count
  • ALDX 2
  • MVIS 4
  • Target Price
  • ALDX $9.50
  • MVIS $2.67
  • AVG Volume (30 Days)
  • ALDX 1.5M
  • MVIS 2.6M
  • Earning Date
  • ALDX 05-20-2025
  • MVIS 05-12-2025
  • Dividend Yield
  • ALDX N/A
  • MVIS N/A
  • EPS Growth
  • ALDX N/A
  • MVIS N/A
  • EPS
  • ALDX N/A
  • MVIS N/A
  • Revenue
  • ALDX N/A
  • MVIS $4,696,000.00
  • Revenue This Year
  • ALDX N/A
  • MVIS $481.03
  • Revenue Next Year
  • ALDX N/A
  • MVIS $140.12
  • P/E Ratio
  • ALDX N/A
  • MVIS N/A
  • Revenue Growth
  • ALDX N/A
  • MVIS N/A
  • 52 Week Low
  • ALDX $1.14
  • MVIS $0.80
  • 52 Week High
  • ALDX $7.20
  • MVIS $1.95
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 34.82
  • MVIS 46.80
  • Support Level
  • ALDX $1.90
  • MVIS $1.07
  • Resistance Level
  • ALDX $2.89
  • MVIS $1.26
  • Average True Range (ATR)
  • ALDX 0.23
  • MVIS 0.06
  • MACD
  • ALDX 0.10
  • MVIS 0.00
  • Stochastic Oscillator
  • ALDX 26.26
  • MVIS 42.11

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

Share on Social Networks: